Invited Speakers
  • Vikas Kumar
    Sam Higginbottom Univ.
    India
  • Dr. Vikas Kumar
    Associate Professor
    Department of Pharmaceutical Sciences
    Faculty of Health Sciences
    Sam Higginbottom University of Agriculture, Technology & Sciences, Prayagraj, India
    Email: phvikas@gmail.com | vikas.kumar@shiats.edu.in


    Dr. Vikas Kumar is an Associate Professor of Pharmacognosy with over 20 years of academic and research experience in natural product drug discovery. His research focuses on traditional medicine-based therapeutic development targeting diseases such as psoriasis, diabetes, cardiovascular disorders, and cancer.
    He completed his Ph.D. in Pharmacognosy from SHUATS, Prayagraj with excellent academic performance (10 CGPA). He also holds an M.Pharm in Pharmacognosy from Dibrugarh University and a B.Pharm from Dehradun. He qualified GATE (2005) with an All India Rank of 1006.
    Dr. Kumar has published more than 160 research articles in peer-reviewed journals, along with 2 books and over 20 book chapters. Dr. Kumar has an extensive research record with more than 161 peer-reviewed publications (cumulative impact factor ≈ 411.67), along with 2 books and over 20 book chapters.
    His scholarly impact is reflected by over 8,053 citations, with an h-index of 45 and i10-index of 152 (Google Scholar).
    He has supervised multiple doctoral scholars (7 scholars as a guide and 8 as co-guides) and actively teaches undergraduate and postgraduate students. His expertise includes phytoconstituent isolation, spectroscopic characterization (IR, NMR, MS), and pharmacological evaluations including antiosteoporosis, anticancer, and antiarthritic studies.
    He is also an inventor with U.S. patents related to cardiac toxicity treatment via gut microbiota and mass spectrometry-based detection of mycotoxins.
    Dr. Kumar has received numerous national and international awards for his contributions to research and education. His work integrates traditional medicinal knowledge with modern pharmacological approaches to develop innovative therapeutic agents.
    • Date Time Room Session Title Lecture Title
    May 15 11:10-11:20 Room 2 (3F) Free Paper Session 5_Osteoarthritis and Pain in Rheumatic Diseases (KO-040) Epigallocatechin Gallate Based pH-Sensitive PEGylated Liposomes Ameliorate Monoiodoacetate-induced Osteoarthritis in Rats via Alteration of HO-1/Nrf2, PI3K/Akt and MAPK Signaling Pathways